Bengaluru-based private healthcare startup Superhealth is reportedly in discussions to raise $10 million from investor Ronnie Screwvala at a $100 million valuation. The company is not a publicly listed firm and cannot be traded on stock exchanges. The funding aims to support its expansion, though the business faces operational risks and scrutiny over its recent public events.
Superhealth, a Bengaluru-based healthcare startup known for its technology-led hospital model, is reportedly in advanced negotiations to raise $10 million in fresh funding. Reports suggest that veteran entrepreneur Ronnie Screwvala is the lead investor in this round, which aims to value the company at approximately $100 million. It is important for investors to note that Superhealth is a private limited company and is not listed on the National Stock Exchange (NSE) or the Bombay Stock Exchange (BSE). Therefore, the company's shares are not available for public trading, and retail investors cannot buy or sell its stock.
The startup, incorporated in 2024, operates under a business model that claims to reduce wait times and commissions through its proprietary AI operating system, dubbed SuperOS. The management uses this technology to handle tasks ranging from patient consultations to surgical planning. The fresh capital is intended to fund the expansion of its physical hospital network, as the company moves to scale its presence beyond its flagship facility in Koramangala.
The company has also been restructuring its leadership to support this growth phase. In August 2026, it appointed Dalvir Singh Suri, a former co-founder of the delivery firm Dunzo, as its Head of Operations. This hire is viewed as a move to bring professional management to the company's logistics and operational workflows as it adds more hospitals to its network.
While the expansion plans are ambitious, the company faces notable business risks. The healthcare sector is capital-intensive, and building a hospital network requires significant spending on land, equipment, and staff, which can put pressure on cash flows. As a private entity, Superhealth remains heavily dependent on continued venture capital support to sustain its operations until it achieves profitability.
Furthermore, the startup has dealt with reputational challenges. The company faced public backlash earlier this year after hosting a live music event at one of its hospital premises. The incident led to criticism regarding the appropriateness of such activities in a clinical environment, highlighting the operational and reputational risks that come with managing public-facing healthcare facilities. For those following the startup ecosystem, the key monitorable remains whether the company can successfully close this funding round and demonstrate that its tech-enabled hospital model can achieve sustained, high-quality clinical operations without further controversy.